20 (AIDX) Income towards Parent Company (2025 - 2026)
20's (AIDX) quarterly Income towards Parent Company came in at -$2.1 million in Q1 2026, down 174.43% YoY from $2.8 million in Q1 2025, and down 174.43% on a QoQ basis from -$764462.0 in Q1 2025.
20 (AIDX) Income towards Parent Company (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Income towards Parent Company data on file, last reported at -$2.1 million in Q1 2026.
- Quarterly Income towards Parent Company fell 174.43% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (changed N/A YoY) and the FY2025 annual result came in at -$3.8 million, up 30.86% from the prior year.
- Income towards Parent Company slipped to -$2.1 million in Q1 2026, from -$764462.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$764462.0 in Q1 2025 to a low of -$2.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.36 Bn | 194.75 Bn | 7.27 Bn |
| 2 | Stryker | 129.99 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.03 Bn | 110.81 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.30 Bn | 73.76 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn |
| 6 | Dexcom | 34.71 Bn | 32.76 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.24 Bn | 32.13 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn |
| 9 | Steris | 23.30 Bn | 22.81 Bn | 684.20 Mn |
| 10 | 20 | 5.45 Mn | 903,174.56 | 304,727.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.10 Mn |
| Mar 31, 2025 | -764,462.00 |